Escolar Documentos
Profissional Documentos
Cultura Documentos
PHARMACEUTICAL SCIENCES
http://doi.org/10.5281/zenodo.1134425
parameters such as drug load, amount of polymer, 10.Chorny M, Fishbein I, Danenberg HD, Golomb G.
drug: polymer ratio, organic solvents, mode and rate Lipophilic drug loaded nanospheres prepared by
of addition of solvent into anti-solvent, nature of anti- nanoprecipitation: effect of formulation variables on
solvent, stabilizers in anti-solvent, pH of anti-solvent, size, drug recovery and release kinetics. J Cont Rel,
ratio of solvent : anti-solvent, stirring rate and 2002;83(3):389-400.
temperature etc. Of all investigated parameters, 11.Legrand P, Lesieur S, Bochot A, Gref R, Raatjes
nature and amount of polymer, solvent and anti- W, Barratt G, Vauthier C. Influence of polymer
solvent were found to affect the size of nanoparticles behaviour in organic solution on the production of
significantly. polylactide nanoparticles by nanoprecipitation. Int J
Pharm, 2007;344(1):33-43.
REFERENCES: 12.Betancourt T, Brown B, Brannon-Peppas L.
1.Fessi HP, Puisieux F, Devissaguet JP, Ammoury N, Doxorubicin-loaded PLGA nanoparticles by
Benita S. Nanocapsule formation by interfacial nanoprecipitation: preparation, characterization and
polymer deposition following solvent displacement. in vitro evaluation. Nanomedicine. 2007;2(2):219-
Int J pharm, 1989; 55(1):R1-4. 232.
2.Quintanar-Guerrero D, Allémann E, Fessi H, 13.Khan WH, Rathod VK. Process intensification
Doelker E. Preparation techniques and mechanisms approach for preparation of curcumin nanoparticles
of formation of biodegradable nanoparticles from via solvent–nonsolvent nanoprecipitation using
preformed polymers. Drug dev ind pharm, 1998 ; spinning disc reactor. Chem Eng Proc: Proc Intens.
24(12):1113-1128. 2014;80:1-10.
3.Govender T, Stolnik S, Garnett MC, Illum L, Davis 14.Hyvönen S, Peltonen L, Karjalainen M, Hirvonen
SS. PLGA nanoparticles prepared by J. Effect of nanoprecipitation on the physicochemical
nanoprecipitation: drug loading and release studies of properties of low molecular weight poly (L-lactic
a water soluble drug. J Cont Rel, 1999 ;57(2):171- acid) nanoparticles loaded with salbutamol sulphate
185. and beclomethasone dipropionate. Int J Pharm,
4.Barichello JM, Morishita M, Takayama K, Nagai 2005;295(1):269-281.
T. Encapsulation of hydrophilic and lipophilic drugs 15.Song KC, Lee HS, Choung IY, Cho KI, Ahn Y,
in PLGA nanoparticles by the nanoprecipitation Choi EJ. The effect of type of organic phase solvents
method. Drug dev ind pharm, 1999;25(4):471-476. on the particle size of poly (d, l-lactide-co-glycolide)
5.Niwa T, Takeuchi H, Hino T, Kunou N, nanoparticles. Coll Surf A: Physicochem Eng Asp.
Kawashima Y. Preparations of biodegradable 2006;276(1):162-167.
nanospheres of water-soluble and insoluble drugs 16.Mainardes RM, Evangelista RC. PLGA
with D, L-lactide/glycolide copolymer by a novel nanoparticles containing praziquantel: effect of
spontaneous emulsification solvent diffusion method, formulation variables on size distribution. Int J
and the drug release behavior. J Cont Rel, 1993;25(1- Pharm, 2005;290(1):137-144.
2):89-98. 17.Lee JS, Hwang SJ, Lee DS, Kim SC, Kim DJ.
6.Stainmesse S, Orecchioni AM, Nakache E, Formation of Poly (ethylene glycol)-Poly (ε-
Puisieux F, Fessi H. Formation and stabilization of a caprolactone) Nanoparticles via Nanoprecipitation.
biodegradable polymeric colloidal suspension of Macromol res, 2009;17(2):72-78.
nanoparticles. Colloid & Polymer Science. 1995 18.Bilati U, Allémann E, Doelker E. Development of
;273(5):505-511. a nanoprecipitation method intended for the
7.Molpeceres J, Guzman M, Aberturas MR, Chacon entrapment of hydrophilic drugs into nanoparticles.
M, Berges L. Application of central composite Eur J Pharm Sci. 2005;24(1):67-75.
designs to the preparation of polycaprolactone 19.Peltonen L, Aitta J, Hyvönen S, Karjalainen M,
nanoparticles by solvent displacement. J pharm sci, Hirvonen J. Improved entrapment efficiency of
1996;85(2):206-213. hydrophilic drug substance during nanoprecipitation
8.Guterres SS, Fessi H, Barratt G, Devissaguet JP, of poly (I) lactide nanoparticles. Aaps Pharmscitech.
Puisieux F. Poly (DL-lactide) nanocapsules 2004;5(1):115.
containing diclofenac: I. Formulation and stability 20.Barichello JM, Morishita M, Takayama K, Nagai
study. Int J Pharm, 1995;113(1):57-63. T. Encapsulation of hydrophilic and lipophilic drugs
9.Jeon HJ, Jeong YI, Jang MK, Park YH, Nah JW. in PLGA nanoparticles by the nanoprecipitation
Effect of solvent on the preparation of surfactant-free method. Drug dev ind pharm, 1999;25(4):471-476.
poly (DL-lactide-co-glycolide) nanoparticles and 21.Bilati U, Allémann E, Doelker E.
norfloxacin release characteristics. Int J Pharm, Nanoprecipitation versus emulsion-based techniques
2000;207(1):99-108. for the encapsulation of proteins into biodegradable